IPF Respiratory Symptoms Management — Current Evidence

16Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic disease of the lungs which is characterized by heavy symptom burden, especially in the last year of life. Despite recently established anti-fibrotic treatment IPF prognosis is one of the worst among interstitial lung diseases. In this review available evidence regarding pharmacological and non-pharmacological management of the main IPF symptoms, dyspnea and cough, is presented.

Cite

CITATION STYLE

APA

Janowiak, P., Szymanowska-Narloch, A., & Siemińska, A. (2022, July 28). IPF Respiratory Symptoms Management — Current Evidence. Frontiers in Medicine. Frontiers Media S.A. https://doi.org/10.3389/fmed.2022.917973

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free